Mar 12, 2019
Micro Medical Solutions Signs Distribution Agreements in 15 Countries for MicroStent Vascular Stent
Jan 07, 2019
Rexgenero's Lead Product REX-001 Selected for the EUnetHTA Prioritisation List for Joint Assessments
Dec 11, 2018
HMP Announces European Launch of Amputation Prevention Symposium (AMP)
Nov 12, 2018
Philips announces first U.S. patient enrolled in ILLUMENATE study of Stellarex 0.014 Drug-Coated Balloon for below-the-knee peripheral artery disease
Nov 07, 2018
BD Announces Clinical Trial Data for the LUTONIX® 014 Drug-Coated Balloon Below-The-Knee IDE Trial
Nov 05, 2018
Micro Medical Solutions' New MicroStent with 120 cm Delivery Catheter Receives CE Mark Approval
Jan 30, 2018
EMA grants Rexgenero's Lead Product REX-001 Advanced Therapy Medicinal Product Certificate for Manufacturing Quality and Non-clinical Data
Jan 25, 2018
Rexgenero Treats First Patient in its Phase III Programme with Lead Product REX-001, a Novel Cell Therapy for the Treatment of Critical Limb Ischemia (CLI)
Jan 18, 2018
BD Announces Completion of Enrollment in the Lutonix(TM) 014 Drug Coated Balloon Below-The-Knee Trial
Nov 13, 2017
Rexgenero Announces the Appointment of Sam MacHour to its Scientific Advisory Board
Oct 30, 2017
Mercator MedSystems Announces Completion of Enrollment in the LIMBO-ATX Trial
Oct 09, 2017
BioTech Holdings Identifies and Files Patent on ProCell Mechanism of Action in Saving Limbs from Amputation
Sep 12, 2017
First Round Of Late-Breaking Endovascular Clinical Trial Results Announced At VIVA 17
Sep 07, 2017
PAD | Often misdiagnosed, this illness can be mild or deadly
Aug 03, 2017
VM BioPharma Announces First Patient Dosed in Phase 3 Study of Gene Therapy Candidate VM202 for Non-Healing Diabetic Foot Ulcers